MarketInOut Stock Screener Log In | Sign Up

BNB Plus Corp

NASDAQ • Financial Services • Asset Management • Quote as of 10/30/2026
BNB Plus Corp stock price and volume chart

Company Profile

IndustryAsset Management
SectorFinancial Services
ExchangeNASDAQ
Market Capitalization0.5701 mln
Float4.25 mln
Earnings Date11/13/2026

EPS

117
Exceptional

P / E

0.00
Anomalous

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-10.67
Highly reliable

Relative Strength

3 / 100
Severely lagging

Debt / Equity

0.41
Low leverage

Business Description

BNB Plus Corp., formerly known as Applied DNA Sciences Inc., is a New York-based company founded in 1983 that manages digital asset treasuries while providing real-time tracking of financial performance and market data. Through its subsidiaries, the company also manufactures and sells specialized biological materials, including synthetic DNA and RNA, used in medicines, diagnostics, and drug development. Its core products serve pharmaceutical and biotech companies across North America, Europe, Asia, and other global markets.

Key Fundamentals

EPS117
P/E0.00
ROE-350
RPS0.43
ROIC-215
ROA-277
EBITDA, mln-35.78
EV / EBITDA-0.04
EV / EBIT-0.04
Revenue, mln2.39
EV / Revenue0.57

Quote Details

Last 0.085
Change -0.025 (-22.73%)
Open 0.0861
Volume 7,967
Turnover 677.2
Average Volume 10,483

Financial Ratios

Pre-Tax Profit Margin-1,504
Leverage Ratio1.09
Current Ratio5.79
Price / Book0.10
Price / Tangible Book0.11
Debt / Equity0.41
Price / Sales0.40
PEG Ratio1.27

Financial Strength

Altman Z-Score-45.6
Piotroski F-Score 4 / 9
Beneish M-Score-10.67
Short Ratio0.68
Short % of Float2.92

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -15% 6 / 100   
1 Month -39.29% 7 / 100   
2 Months -5.56% 40 / 100   
6 Months -82.86% 4 / 100   
1 Year -97.55% 2 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog